FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978396783> ?p ?o ?g. }

• W1978396783 endingPage "24" @default.
• W1978396783 startingPage "17" @default.
• W1978396783 abstract "Nitric oxide (NO) donors have been shown to activate or inhibit constitutively-activated survival/anti-apoptotic pathways, such as NF-κB, in cancer cells. We report here that treatment of drug-resistant human prostate carcinoma cell lines with high levels (500-1000 μM) of the NO-donor DETANONOate sensitized the resistant tumor cells to apoptosis by CDDP and the combination was synergistic. We hypothesized that DETANONOate inhibits previously identified NF-κB-regulated resistant factors such as Yin Yang 1 (YY1) and Bcl-2/BclXL. Lysates from tumor cells treated with DETANONOate showed inhibition of YY1 and BclXL expressions. Transfection with either YY1 or BclXL siRNA resulted in the inhibition of both YY1 and BclXL expressions and sensitized the cells to CDDP apoptosis. Mice bearing PC-3 tumor xenografts and treated with the combination of DETANONOate and CDDP resulted in significant inhibition of tumor growth; treatment with single agent alone did not have any effect on tumor growth. Analysis of patients TMA tissues with prostatic cancer revealed higher expression of both YY1 and BclXL as a function of tumor grades and their levels were directly correlated. Thus, both YY1 and BclXL are potential prognostic biomarkers. Overall, the above findings suggest that one mechanism of DETANONOate-induced sensitization of resistant tumor cells to CDDP correlated with the inhibition of NF-κB and its targets YY1 and BclXL. The examination of the combination of NO donors and cytotoxic therapy in the treatment of resistant prostate cancer may be warranted." @default.
• W1978396783 created "2016-06-24" @default.
• W1978396783 creator A5011522973 @default.
• W1978396783 creator A5024653131 @default.
• W1978396783 creator A5040181572 @default.
• W1978396783 creator A5055490703 @default.
• W1978396783 creator A5078486942 @default.
• W1978396783 creator A5082889084 @default.
• W1978396783 creator A5091584908 @default.
• W1978396783 date "2013-02-01" @default.
• W1978396783 modified "2023-10-18" @default.
• W1978396783 title "Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer" @default.
• W1978396783 cites W1755870104 @default.
• W1978396783 cites W1963966302 @default.
• W1978396783 cites W1982590355 @default.
• W1978396783 cites W1983706975 @default.
• W1978396783 cites W1984545880 @default.
• W1978396783 cites W1998118468 @default.
• W1978396783 cites W2023544069 @default.
• W1978396783 cites W2024663996 @default.
• W1978396783 cites W2026038242 @default.
• W1978396783 cites W2033040828 @default.
• W1978396783 cites W2045752058 @default.
• W1978396783 cites W2048139135 @default.
• W1978396783 cites W2049811880 @default.
• W1978396783 cites W2050227906 @default.
• W1978396783 cites W2073672111 @default.
• W1978396783 cites W2078324381 @default.
• W1978396783 cites W2084865991 @default.
• W1978396783 cites W2087057672 @default.
• W1978396783 cites W2112191861 @default.
• W1978396783 cites W2119197910 @default.
• W1978396783 cites W2124660181 @default.
• W1978396783 cites W2128041404 @default.
• W1978396783 cites W2152114243 @default.
• W1978396783 cites W2155484255 @default.
• W1978396783 cites W2159515687 @default.
• W1978396783 cites W2167451931 @default.
• W1978396783 doi "https://doi.org/10.1016/j.niox.2012.12.001" @default.
• W1978396783 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23246440" @default.
• W1978396783 hasPublicationYear "2013" @default.
• W1978396783 type Work @default.
• W1978396783 sameAs 1978396783 @default.
• W1978396783 citedByCount "53" @default.
• W1978396783 countsByYear W19783967832013 @default.
• W1978396783 countsByYear W19783967832014 @default.
• W1978396783 countsByYear W19783967832015 @default.
• W1978396783 countsByYear W19783967832016 @default.
• W1978396783 countsByYear W19783967832017 @default.
• W1978396783 countsByYear W19783967832018 @default.
• W1978396783 countsByYear W19783967832019 @default.
• W1978396783 countsByYear W19783967832020 @default.
• W1978396783 countsByYear W19783967832021 @default.
• W1978396783 countsByYear W19783967832022 @default.
• W1978396783 countsByYear W19783967832023 @default.
• W1978396783 crossrefType "journal-article" @default.
• W1978396783 hasAuthorship W1978396783A5011522973 @default.
• W1978396783 hasAuthorship W1978396783A5024653131 @default.
• W1978396783 hasAuthorship W1978396783A5040181572 @default.
• W1978396783 hasAuthorship W1978396783A5055490703 @default.
• W1978396783 hasAuthorship W1978396783A5078486942 @default.
• W1978396783 hasAuthorship W1978396783A5082889084 @default.
• W1978396783 hasAuthorship W1978396783A5091584908 @default.
• W1978396783 hasConcept C121608353 @default.
• W1978396783 hasConcept C126322002 @default.
• W1978396783 hasConcept C150903083 @default.
• W1978396783 hasConcept C185592680 @default.
• W1978396783 hasConcept C190283241 @default.
• W1978396783 hasConcept C207001950 @default.
• W1978396783 hasConcept C2780192828 @default.
• W1978396783 hasConcept C502942594 @default.
• W1978396783 hasConcept C54009773 @default.
• W1978396783 hasConcept C54355233 @default.
• W1978396783 hasConcept C55493867 @default.
• W1978396783 hasConcept C71924100 @default.
• W1978396783 hasConcept C81885089 @default.
• W1978396783 hasConcept C86803240 @default.
• W1978396783 hasConcept C98274493 @default.
• W1978396783 hasConceptScore W1978396783C121608353 @default.
• W1978396783 hasConceptScore W1978396783C126322002 @default.
• W1978396783 hasConceptScore W1978396783C150903083 @default.
• W1978396783 hasConceptScore W1978396783C185592680 @default.
• W1978396783 hasConceptScore W1978396783C190283241 @default.
• W1978396783 hasConceptScore W1978396783C207001950 @default.
• W1978396783 hasConceptScore W1978396783C2780192828 @default.
• W1978396783 hasConceptScore W1978396783C502942594 @default.
• W1978396783 hasConceptScore W1978396783C54009773 @default.
• W1978396783 hasConceptScore W1978396783C54355233 @default.
• W1978396783 hasConceptScore W1978396783C55493867 @default.
• W1978396783 hasConceptScore W1978396783C71924100 @default.
• W1978396783 hasConceptScore W1978396783C81885089 @default.
• W1978396783 hasConceptScore W1978396783C86803240 @default.
• W1978396783 hasConceptScore W1978396783C98274493 @default.
• W1978396783 hasLocation W19783967831 @default.
• W1978396783 hasLocation W19783967832 @default.
• W1978396783 hasOpenAccess W1978396783 @default.
• W1978396783 hasPrimaryLocation W19783967831 @default.
• W1978396783 hasRelatedWork W123250343 @default.

• next